Transgenic knockouts as part of high-throughput, evidence-based target selection and validation strategies
- 8 June 2001
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (12) , 628-636
- https://doi.org/10.1016/s1359-6446(01)01794-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Impact of human genome sequencing for in silico target discoveryDrug Discovery Today, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Transgenic gene knock-outs: functional genomics and therapeutic target selectionPharmacogenomics, 2000
- How to count…human genesNature Genetics, 2000
- Drug Discovery: A Historical PerspectiveScience, 2000
- Genomics and intellectual property rightsDrug Discovery Today, 1999
- Genomics: the race is onDrug Discovery Today, 1999
- Functional genomics: from genes to new therapiesDrug Discovery Today, 1999
- Obtaining value from the human genome: a challenge for the pharmaceutical industryDrug Discovery Today, 1998
- Genomic sciences and the medicine of tomorrowNature Biotechnology, 1996